start portlet menu bar

การขอดูเนื้อหาบนเว็บ

Display portlet menu
end portlet menu bar

Safety concerns regarding coccidiosis vaccines. Comparison of attenuated and non-attenuated vaccines

หน้าหลัก ความรู้ Safety concerns regarding coccidiosis vaccines. Comparison of attenuated and non-attenuated vaccines

Safety concerns regarding coccidiosis vaccines. Comparison of attenuated and non-attenuated vaccines

The aim of this study was to compare the safety parameters of commercial non-attenuated and attenuated (Jeffers, 1975) Eimeria vaccines with EVALON®, a live attenuated coccidiosis vaccine for breeders and layers. 525 chickens were vaccinated orally at 1 day of age with either PBS (group 1), an attenuated vaccine (groups 2 and 4), including EVALON® (HIPRA) (group 2), or non-attenuated vaccines (groups 3 and 5).

เกี่ยวกับบทความ

ตามที่ปรากฎ

WVPA Congress, 2017

วันที่

28 ก.ย. 2560

ผู้แต่ง

Dardi, M.; Baratelli, M.; Boix, O.; Pagès, M.

บทสรุป

The outcomes of this trial suggest that both attenuation and also its grade might be important factors to take into account when selecting live coccidiosis vaccines. This study also supports the safety of EVALON®, a live attenuated vaccine designed to confer protection without compromising the health status of vaccinated animals.

ผลิตภัณฑ์ที่เกี่ยวข้อง

แบ่งปัน